Alopecia areata: evidence-based treatments
- PMID: 19341938
- DOI: 10.1016/j.sder.2008.12.002
Alopecia areata: evidence-based treatments
Abstract
Alopecia areata is a common condition causing nonscarring hair loss. It may be patchy, involve the entire scalp (alopecia totalis) or whole body (alopecia universalis). Patients may recover spontaneously but the disorder can follow a course of recurrent relapses or result in persistent hair loss. Alopecia areata can cause great psychological distress, and the most important aspect of management is counseling the patient about the unpredictable nature and course of the condition as well as the available effective treatments, with details of their side effects. Although many treatments have been shown to stimulate hair growth in alopecia areata, there are limited data on their long-term efficacy and impact on quality of life. We review the evidence for the following commonly used treatments: corticosteroids (topical, intralesional, and systemic), topical sensitizers (diphenylcyclopropenone), psoralen and ultraviolet A phototherapy (PUVA), minoxidil and dithranol.
Similar articles
-
Topical and intralesional therapies for alopecia areata.Dermatol Ther. 2011 May-Jun;24(3):355-63. doi: 10.1111/j.1529-8019.2011.01419.x. Dermatol Ther. 2011. PMID: 21689245 Review.
-
Alopecia areata.Am Fam Physician. 1990 Apr;41(4):1197-201. Am Fam Physician. 1990. PMID: 2181836 Review.
-
Determination of the sildenafil effect on alopecia areata in childhood: An open-pilot comparison study.J Dermatolog Treat. 2006;17(4):235-7. doi: 10.1080/09546630600895003. J Dermatolog Treat. 2006. PMID: 16971319 Clinical Trial.
-
PUVA treatment of alopecia areata.Arch Dermatol. 1983 Dec;119(12):975-8. Arch Dermatol. 1983. PMID: 6651314 Clinical Trial.
-
Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.Clin Exp Dermatol. 2007 Jan;32(1):48-51. doi: 10.1111/j.1365-2230.2006.02256.x. Epub 2006 Sep 27. Clin Exp Dermatol. 2007. PMID: 17004987 Clinical Trial.
Cited by
-
The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias.FASEB J. 2013 Feb;27(2):557-67. doi: 10.1096/fj.12-218156. Epub 2012 Oct 26. FASEB J. 2013. PMID: 23104985 Free PMC article.
-
Lasers in the management of alopecia: a review of established therapies and advances in treatment.Lasers Med Sci. 2024 Apr 17;39(1):102. doi: 10.1007/s10103-024-04054-7. Lasers Med Sci. 2024. PMID: 38630348 Free PMC article. Review.
-
COVID-19 Pandemic Impact on Severe Alopecia Areata Patients.Skin Appendage Disord. 2022 May;8(3):195-199. doi: 10.1159/000520422. Epub 2021 Dec 20. Skin Appendage Disord. 2022. PMID: 35698587 Free PMC article.
-
Efficacy and Safety of Methotrexate in Combination with Mini Pulse Doses of Methylprednisolone in Severe Alopecia Areata. The Vietnamese Experience.Open Access Maced J Med Sci. 2019 Jan 23;7(2):200-203. doi: 10.3889/oamjms.2019.004. eCollection 2019 Jan 30. Open Access Maced J Med Sci. 2019. PMID: 30745958 Free PMC article.
-
Efficacy of fractional lasers in treating alopecia: a literature review.Lasers Med Sci. 2017 Nov;32(8):1919-1925. doi: 10.1007/s10103-017-2306-7. Epub 2017 Aug 16. Lasers Med Sci. 2017. PMID: 28812164 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical